These include increased dependencies on ISL1, GATA3, and MYCN in neuroblastoma, all of which were recently reported as part of the core regulatory circuitry (CRC) in neuroblastoma and associated with superenhancers.83 The gene discussed is MYCN; the disease is neuroblastoma.